DeCure for Klippel-Feil syndrome 1, autosomal dominant
DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for Klippel-Feil syndrome 1, autosomal dominant — screening already-approved drugs against its 1-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleKlippel-Feil syndrome 1, autosomal dominant maps to a 1-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for klippel-feil syndrome 1, autosomal dominant is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
What the evidence adds up to
In a 1975 study of thirty-nine patients with Klippel-Feil syndrome, twenty-five (64 per cent) had significant genitourinary-tract anomalies demonstrated by intravenous urogram and physical examination. The incidence of these anomalies was essentially the same across Feil's three types of the syndrome, with unilateral renal agenesis being the most common. The authors concluded that a routine intravenous urogram is indicated in patients with this syndrome.
A 2008 case report described a young girl with Klippel-Feil syndrome and situs inversus, noting this as an extremely rare association. The clinical triad of KFS—short neck, low posterior hairline, and limited neck movement—was present, and the report discussed various systemic associations occurring in this multi-system disorder.
A 2021 case report described a child with Klippel-Feil syndrome and situs inversus totalis, again noting this as an extremely rare association. The authors reviewed the known genetic background of both conditions, stating that both KFS and situs inversus totalis are genetically heterogeneous and that their co-occurrence suggests a high possibility of sharing the same underlying causative agent.
No drug treatment or intervention is mentioned in any of these abstracts. What is still missing is any trial design, patient stratification, or funding for a therapeutic approach, as the literature remains limited to descriptive case series and reports of anatomical associations.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
Journal of Bone and Joint Surgery · 1975 · 80 citations
Genitourinary anomalies associated with Klippel-Feil syndrome
AbstractOf thirty-nine patients with Klippel-Feil syndrome, twenty-five (64 per cent) had significant genitourinary-tract anomalies demonstrated by intravenous urogram and physical examination. The incidence of these anomalies in Feil's three types of the syndrome was essentially the same, unilateral renal agenesis being the most common. A routine intravenous urogram is indicated in patients with this syndrome.
Klippel-Feil syndrome with situs inversus--a rare association.
AbstractKlippel-Feil Syndrome (KFS) is a congenital anomaly characterized by a defect in the formation or segmentation of the cervical vertebrae. The clinical triad consists of short neck, low posterior hairline and limited neck movement. Multiple congenital anomalies have been associated with this disease. This is a case of KFS in a young girl along with situs inversus, which is an extremely rare association. Various systemic associations occurring in this multi-system disorder are also discussed.
BMJ Case Reports · 2021 · 2 citations · open access
Rare association of Klippel-Feil syndrome with situs inversus totalis and review of the genetic background
AbstractKlippel-Feil syndrome (KFS) is a rare congenital anomaly in forming the cervical vertebrae resulting in the fusion of two or more of the vertebrae. KFS is associated with many congenital anomalies, some of which are common and well known. Here, we report a child with an extremely rare association of KFS with situs inversus totalis (SIT). Both KFS and SIT are genetically heterogeneous and their co-occurrence suggests a high possibility of sharing the same underlying causative agent. Here, we review the genetic background that is known for these two conditions in the literature.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
